The DOI matches its Crossref record; 654 of the 654 references it cites were found in a registry or an index.
Inhibitors of Protein Methyltransferases and Demethylases
Open accessAbstract
Post-translational modifications of histones by protein methyltransferases (PMTs) and histone demethylases (KDMs) play an important role in the regulation of gene expression and transcription and are implicated in cancer and many other diseases. Many of these enzymes also target various nonhistone proteins impacting numerous crucial biological pathways. Given their key biological functions and implications in human diseases, there has been a growing interest in assessing these enzymes as potential therapeutic targets. Consequently, discovering and developing inhibitors of these enzymes has become a very active and fast-growing research area over the past decade. In this review, we cover the discovery, characterization, and biological application of inhibitors of PMTs and KDMs with emphasis on key advancements in the field. We also discuss challenges, opportunities, and future directions in this emerging, exciting research field.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 401–600 of 654
Horton, J. R., Engstrom, A., Zoeller, E. L., Liu, X., Shanks, J. R., Zhang, X., Johns, M. A., Vertino, P. M., Fu, H., & Cheng, X. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.698449 · Cited by 136
Willmann, D., Lim, S., Wetzel, S., Metzger, E., Jandausch, A., Wilk, W., Jung, M., Forné, I., Imhof, A., Janzer, A., et al. (2012) · International Journal of Cancer · doi:10.1002/ijc.27555 · Cited by 135
Chen, L., Deshpande, A. J., Banka, D., Bernt, K. M., Dias, S., Buske, C., Olhava, E. J., Daigle, S. R., Richon, V. M., Pollock, R. M., et al. (2012) · Leukemia · doi:10.1038/leu.2012.327 · Cited by 135
EPZ011989, A Potent, Orally-Available EZH2 Inhibitor with Robust in Vivo Activity
Campbell, J. E., Kuntz, K. W., Knutson, S. K., Warholic, N. M., Keilhack, H., Wigle, T. J., Raimondi, A., Klaus, C. R., Rioux, N., Yokoi, A., et al. (2015) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.5b00037 · Cited by 134
Ding, L., Erdmann, C. A., Chinnaiyan, A. M., Merajver, S. D., & Kleer, C. G. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4300 · Cited by 132
The SUV4-20 inhibitor A-196 verifies a role for epigenetics in genomic integrity
Bromberg, K. D., Mitchell, T. R. H., Upadhyay, A. K., Jakob, C. G., Jhala, M. A., Comess, K. M., Lasko, L. M., Li, C., Tuzon, C. T., Dai, Y., et al. (2017) · Nature Chemical Biology · doi:10.1038/nchembio.2282 · Cited by 132
Ndy1/KDM2B immortalizes mouse embryonic fibroblasts by repressing the Ink4a / Arf locus
Tzatsos, A., Pfau, R., Kampranis, S. C., & Tsichlis, P. N. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813139106 · Cited by 131
Small Molecule Inhibitors of Protein Arginine Methyltransferases
Hu, H., Qian, K., Ho, M., & Zheng, Y. G. (2016) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2016.1144747 · Cited by 131
CARM1 Regulates Proliferation of PC12 Cells by Methylating HuD
Fujiwara, T., Mori, Y., Chu, D. L., Koyama, Y., Miyata, S., Tanaka, H., Yachi, K., Kubo, T., Yoshikawa, H., & Tohyama, M. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.6.2273-2285.2006 · Cited by 130
Sakamaki, J.-I., Daitoku, H., Ueno, K., Hagiwara, A., Yamagata, K., & Fukamizu, A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1015328108 · Cited by 130
A SMYD3 Small‐Molecule Inhibitor Impairing Cancer Cell Growth
Peserico, A., Germani, A., Sanese, P., Barbosa, A. J. M., Virgilio, V. D., Fittipaldi, R., Fabini, E., Bertucci, C., Varchi, G., Moyer, M. P., et al. (2015) · Journal of Cellular Physiology · doi:10.1002/jcp.24975 · Cited by 128
Non‐Competitive Inhibition by Active Site Binders
Blat, Y. (2010) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2010.00972.x · Cited by 127
Molecular Basis for the Regulation of the H3K4 Methyltransferase Activity of PRDM9
Wu, H. Y., Mathioudakis, N., Diagouraga, B., Dong, A., Dombrovski, L., Baudat, F., Cusack, S., de Massy, B., & Kadlec, J. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.08.035 · Cited by 126
Adding a Lysine Mimic in the Design of Potent Inhibitors of Histone Lysine Methyltransferases
Chang, Y., Ganesh, T., Horton, J. R., Spannhoff, A., Liu, J., Sun, A., Zhang, X., Bedford, M. T., Shinkai, Y., Snyder, J. P., et al. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.04.048 · Cited by 126
Structure–function relationships of human JmjC oxygenases—demethylases versus hydroxylases
Markolovic, S., Leissing, T. M., Chowdhury, R., Wilkins, S. E., Lü, X., & Schofield, C. J. (2016) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2016.05.013 · Cited by 126
Rotili, D., Tomassi, S., Conte, M., Benedetti, R., Tortorici, M., Ciossani, G., Valente, S., Marrocco, B., Labella, D., Novellino, E., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm4012802 · Cited by 125
Shia, W.-J., Okumura, A. J., Yan, M., Sarkeshik, A., Lo, M., Matsuura, S., Komeno, Y., Zhao, X., Nimer, S. D., Yates, J. R., et al. (2012) · Blood · doi:10.1182/blood-2011-04-347476 · Cited by 124
Cell-Type-Specific Control of Enhancer Activity by H3K9 Trimethylation
Zhu, Y., van Essen, D., & Saccani, S. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.05.011 · Cited by 124
Proteomic analyses of the SMYD family interactomes identify HSP90 as a novel target for SMYD2
Abu‐Farha, M., Lanouette, S., Elisma, F., Tremblay, V., Butson, J., Figeys, D., & Couture, J. (2011) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjr025 · Cited by 124
Brain-Penetrant LSD1 Inhibitors Can Block Memory Consolidation
Neelamegam, R., Ricq, E. L., Malvaez, M., Patnaik, D., Norton, S., Carlin, S. M., Hill, I. T., Wood, M. A., Haggarty, S. J., & Hooker, J. M. (2011) · ACS Chemical Neuroscience · doi:10.1021/cn200104y · Cited by 123
The lysine demethylase, KDM4B, is a key molecule in androgen receptor signalling and turnover
Coffey, K., Rogerson, L., Ryan-Munden, C. A., Alkharaif, D., Stockley, J., Heer, R., Sahadevan, K., O'Neill, D. J., Jones, D., Darby, S., et al. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt106 · Cited by 123
Zhang, P., Lee, H., Brunzelle, J. S., & Couture, J. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr1235 · Cited by 122
Singh, V., Miranda, T. B., Jiang, W., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1208057 · Cited by 122
Koh, S. S., Li, H., Lee, Y., Widelitz, R. B., Chuong, C., & Stallcup, M. R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110865200 · Cited by 121
Hou, J., Wu, J., Dombkowski, A. A., Zhang, K., Holowatyj, A., Boerner, J. L., & Yang, Z. Q. (2012) · Europe PMC (PubMed Central) · Cited by 119
Kong, X., Chen, L., Jiao, L., Jiang, X., Lian, F., Lu, J., Zhu, K., Du, D., Liu, J., Ding, H., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm501230c · Cited by 119
Shi, J., Wang, E., Zuber, J. A., Rappaport, A., Taylor, M. J., Johns, C., Lowe, S. W., & Vakoc, C. R. (2012) · Oncogene · doi:10.1038/onc.2012.110 · Cited by 119
Structural and Biochemical Insights into MLL1 Core Complex Assembly
Avdic, V., Zhang, P., Lanouette, S., Groulx, A. F., Tremblay, V., Brunzelle, J. S., & Couture, J. (2011) · Structure · doi:10.1016/j.str.2010.09.022 · Cited by 118
Discovery of a Selective, Substrate-Competitive Inhibitor of the Lysine Methyltransferase SETD8
Ma, A., Yu, W., Li, F., Bleich, R. M., Herold, J. M., Butler, K. V., Norris, J. L., Korboukh, V. K., Tripathy, A., Janzen, W. P., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500871s · Cited by 117
Self-citationThe active site of the SET domain is constructed on a knot
Jacobs, S. A., Harp, J. M., Devarakonda, S., Kim, Y., Rastinejad, F., & Khorasanizadeh, S. (2002) · Nature Structural Biology · doi:10.1038/nsb861 · Cited by 117
Histone Demethylase RBP2 Is Critical for Breast Cancer Progression and Metastasis
Cao, J. P., Liu, Z. Z., Cheung, W. K. C., Zhao, M., Chen, S. Y., Chan, S. W., Booth, C. J., Nguyen, D. X., & Yan, Q. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.02.004 · Cited by 117
Carr, S. M., Munro, S., Kessler, B. M., Oppermann, U. C. T., & Thangue, N. B. L. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.311 · Cited by 115
Repression of hypoxia-inducible factor α signaling by Set7-mediated methylation
Liu, X., Chen, Z., Xu, C., Leng, X., Cao, H., Ouyang, G., & Xiao, W. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv379 · Cited by 114
Chaetocin is a nonspecific inhibitor of histone lysine methyltransferases
Cherblanc, F., Chapman, K. L., Brown, R. E., & Fuchter, M. J. (2013) · Nature Chemical Biology · doi:10.1038/nchembio.1187 · Cited by 114
Protein Arginine Methylation and Citrullination in Epigenetic Regulation
Fuhrmann, J., & Thompson, P. R. (2015) · ACS Chemical Biology · doi:10.1021/acschembio.5b00942 · Cited by 113
Bissinger, E.-M., Heinke, R., Spannhoff, A., Eberlin, A., Metzger, E., Cura, V., Hassenboehler, P., Cavarelli, J., Schüle, R., Bedford, M. T., et al. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.02.032 · Cited by 112
Xu, G., Liu, G., Xiong, S., Liu, H., Chen, X., & Zheng, B. Q. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.610345 · Cited by 111
Olsen, J. B., Cao, X.-J., Han, B., Chen, L. H., Horvath, A., Richardson, T. I., Campbell, R. M., Garcia, B. A., & Nguyen, H. (2016) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m115.053280 · Cited by 111
Piao, L., Kang, D., Suzuki, T., Masuda, A., Dohmae, N., Nakamura, Y., & Hamamoto, R. (2014) · Neoplasia · doi:10.1016/j.neo.2014.03.002 · Cited by 110
Structural Chemistry of Human SET Domain Protein Methyltransferases
Schapira, M. (2011) · Current Chemical Genomics · doi:10.2174/1875397301005010085 · Cited by 110
Role of Hypoxia‐Inducible Factors in Epigenetic Regulation via Histone Demethylases
Yang, J., Ledaki, I., Turley, H., Gatter, K. C., Montero, J. M., Li, J., & Harris, A. L. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05027.x · Cited by 110
Veschi, V., Liu, Z., Voss, T. C., Ozbun, L. L., Gryder, B. E., Yan, C., Hu, Y., Ma, A., Jin, J. J., Mazur, S. J., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2016.12.002 · Cited by 110
Self-citationA Selective Phenelzine Analogue Inhibitor of Histone Demethylase LSD1
Prusevich, P., Kalin, J. H., Ming, S. A., Basso, M., Givens, J., Li, X., Hu, J., Taylor, M. S., Cieniewicz, A. M., Hsiao, P.-Y., et al. (2014) · ACS Chemical Biology · doi:10.1021/cb500018s · Cited by 109
Ragno, R., Simeoni, S., Castellano, S., Vicidomini, C., Mai, A., Caroli, A., Tramontano, A. L., Bonaccini, C., Trojer, P., Bauer, I., et al. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm061213n · Cited by 109
Structural basis for CARM1 inhibition by indole and pyrazole inhibitors
Sack, J. S., Thieffine, S., Bandiera, T., Fasolini, M., Duke, G. J., Jayaraman, L., Kish, K., Klei, H. E., Purandare, A. V., Rosettani, P., et al. (2011) · Biochemical Journal · doi:10.1042/bj20102161 · Cited by 109
Methylation by Set9 modulates FoxO3 stability and transcriptional activity
Calnan, D. R., Webb, A. E., White, J. L., Stowe, T. R., Goswami, T., Shi, X., Espejo, A. B., Bedford, M. T., Gozani, O., Gygi, S. P., et al. (2012) · Aging · doi:10.18632/aging.100471 · Cited by 109
Huang, Y. R., Zhang, J., Yu, Z., Zhang, H., Wang, Y., Lingel, A., Qi, W., Gu, J., Zhao, K., Shultz, M. D., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01576 · Cited by 109
The MRE11 GAR motif regulates DNA double-strand break processing and ATR activation
Yu, Z., Vogel, G., Coulombe, Y., Dubeau, D., Spehalski, E. I., Hébert, J., Ferguson, D. O., Masson, J., & Richard, S. (2011) · Cell Research · doi:10.1038/cr.2011.128 · Cited by 108
The JMJD2A demethylase regulates apoptosis and proliferation in colon cancer cells
Kim, T., Shin, S., Berry, W. L., Oh, S., & Janknecht, R. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24009 · Cited by 108
The histone demethylase UTX regulates stem cell migration and hematopoiesis
Thieme, S., Gyárfás, T., Richter, C., Özhan, G., Fu, J., Alexopoulou, D., Muders, M. H., Michalk, I., Jakob, C., Dahl, A., et al. (2013) · Blood · doi:10.1182/blood-2012-08-452003 · Cited by 107
Chu, C., Wang, L., Hsu, K., Chen, C.-C., Cheng, H.-H., Wang, S.-M., Wu, C.-M., Chen, T., Li, L.-T., Liu, R., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500249n · Cited by 106
Diamidine Compounds for Selective Inhibition of Protein Arginine Methyltransferase 1
Yan, L., Yan, C., Qian, K., Su, H., Kofsky-Wofford, S. A., Lee, W.-C., Zhao, X., Ho, M., Ivanov, I. N., & Zheng, Y. G. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401884z · Cited by 106
Structural Basis for KDM5A Histone Lysine Demethylase Inhibition by Diverse Compounds
Horton, J. R., Liu, X., Gale, M., Wu, L., Shanks, J. R., Zhang, X., Webber, P. J., Bell, J. S. K., Kales, S. C., Mott, B. T., et al. (2016) · Cell chemical biology · doi:10.1016/j.chembiol.2016.06.006 · Cited by 106
Ribosomal oxygenases are structurally conserved from prokaryotes to humans
Chowdhury, R., Sekirnik, R., Brissett, N. C., Krojer, T., Ho, C.-H., Ng, S. S., Clifton, I. J., Ge, W., Kershaw, N. J., Fox, G. C., et al. (2014) · Nature · doi:10.1038/nature13263 · Cited by 105
Methyltransferase G9A regulates T cell differentiation during murine intestinal inflammation
Antignano, F., Burrows, K., Hughes, M. R., Han, J. M., Kron, K. J., Penrod, N. M., Oudhoff, M. J., Wang, S. K. H., Min, P. H., Gold, M. J., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci69592 · Cited by 104
A novel arginine methyltransferase inhibitor with cellular activity
Spannhoff, A., Machmur, R., Heinke, R., Trojer, P., Bauer, I., Brosch, G., Schüle, R., Hanefeld, W., Sippl, W., & Jung, M. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.05.088 · Cited by 104
Al-Dhaheri, M. H., Wu, J., Skliris, G. P., Li, J., Higashimato, K., Wang, Y., White, K. P., Lambert, P. F., Zhu, Y., Murphy, L. C., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2426 · Cited by 103
Abidi, F., Miano, M. G., Murray, J., & Schwartz, C. (2007) · Clinical Genetics · doi:10.1111/j.1399-0004.2007.00817.x · Cited by 103
Deregulated expression of selected histone methylases and demethylases in prostate carcinoma
Vieira, F. Q., Costa‐Pinheiro, P., Ramalho-Carvalho, J., Faria‐Pereira, A., Menezes, F. D., Antunes, L., Carneiro, I. C., Oliveira, J., Henrique, R., & Jerónimo, C. (2013) · Endocrine Related Cancer · doi:10.1530/erc-13-0375 · Cited by 103
Glycemic memory associated epigenetic changes
Siebel, A. L., Fernández, A. Z., & El‐Osta, A. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.06.005 · Cited by 102
An Allosteric Inhibitor of Protein Arginine Methyltransferase 3
Siarheyeva, A., Senisterra, G. A., Allali‐Hassani, A., Dong, A., Dobrovetsky, E., Wasney, G. A., Chau, I., Marcellus, R. C., Hajian, T., Liu, F., et al. (2012) · Structure · doi:10.1016/j.str.2012.06.001 · Cited by 102
Self-citationMethylation of the Tumor Suppressor Protein, BRCA1, Influences Its Transcriptional Cofactor Function
Guendel, I., Carpio, L., Pedati, C., Schwartz, A. M., Teal, C. B., Kashanchi, F., & Kehn‐Hall, K. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011379 · Cited by 101
Chaturvedi, C.-P., Somasundaram, B., Singh, K., Carpenedo, R. L., Stanford, W. L., Dilworth, F. J., & Brand, M. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1213951109 · Cited by 101
Inner workings and regulatory inputs that control Polycomb repressive complex 2
O’Meara, M., & Simon, J. A. (2012) · Chromosoma · doi:10.1007/s00412-012-0361-1 · Cited by 101
Bavetsias, V., Lanigan, R. M., Ruda, G. F., Atrash, B., McLaughlin, M., Tumber, A., Mok, N. Y., Bihan, Y. L., Dempster, S., Boxall, K. J., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01635 · Cited by 100
The oxygenase Jmjd6–a case study in conflicting assignments
Böttger, A., Islam, M. S., Chowdhury, R., Schofield, C. J., & Wolf, A. (2015) · Biochemical Journal · doi:10.1042/bj20150278 · Cited by 100
He, S., Senter, T. J., Pollock, J., Han, C., Upadhyay, S. K., Purohit, T., Gogliotti, R. D., Lindsley, C. W., Cierpicki, T., Stauffer, S. R., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401868d · Cited by 99
Discovery of a Dual PRMT5–PRMT7 Inhibitor
Smil, D. V., Eram, M. S., Li, F., Kennedy, S., Szewczyk, M. M., Brown, P. J., Baršytė-Lovejoy, D., Arrowsmith, C. H., Vedadi, M., & Schapira, M. (2015) · ACS Medicinal Chemistry Letters · doi:10.1021/ml500467h · Cited by 99
In Situ Generation of a Bisubstrate Analogue for Protein Arginine Methyltransferase 1
Osborne, T. C., Weller, R. L., Rajski, S. R., & Thompson, P. R. (2008) · Journal of the American Chemical Society · doi:10.1021/ja077104v · Cited by 98
Svotelis, A., Bianco, S., Madore, J., Huppé, G., Nordell-Markovits, A., Mes‐Masson, A., & Gévry, N. Y. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.284 · Cited by 98
Mechanistic Analysis of a Suicide Inactivator of Histone Demethylase LSD1
Szewczuk, L. M., Culhane, J. C., Yang, M., Majumdar, A. K., Yu, H., & Cole, P. A. (2007) · Biochemistry · doi:10.1021/bi700414b · Cited by 98
Shen, Y., Szewczyk, M. M., Eram, M. S., Smil, D. V., Kanıskan, H. Ü., de Freitas, R. F., Senisterra, G. A., Li, F., Schapira, M., Brown, P. J., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01033 · Cited by 98
Self-citationPyrazole inhibitors of coactivator associated arginine methyltransferase 1 (CARM1)
Purandare, A. V., Chen, Z., Huynh, T., Pang, S., Geng, J., Vaccaro, W. D., Poss, M. A., O’Connell, J. C., Nowak, K., & Jayaraman, L. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.06.026 · Cited by 97
Chung, J.-H., Karkhanis, V. A., Tae, S., Yan, F., Smith, P. L., Ayers, L. W., Agostinelli, C., Pileri, S. A., Denis, G. V., Baiocchi, R. A., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.510669 · Cited by 97
Expression of nitric oxide related enzymes in coronary heart disease
Chen, X., Niroomand, F., Liu, Z., Zankl, A. R., Katus, H. A., Jahn, L., & Tiefenbacher, C. (2006) · Basic Research in Cardiology · doi:10.1007/s00395-006-0592-5 · Cited by 97
Lu, Y., Beezhold, K., Chang, Q., Zhang, Y., Rojanasakul, Y., Zhao, H., Castranova, V., Shi, X., & Chen, F. (2009) · Cell Cycle · doi:10.4161/cc.8.13.8927 · Cited by 96
Kottakis, F., Foltopoulou, P. F., Sanidas, I., Keller, P. J., Wronski, A., Dake, B. T., Ezell, S. A., Shen, Z., Naber, S. P., Hinds, P. W., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2733 · Cited by 96
Selvi, B. R., Batta, K., Kishore, A. H., Mantelingu, K., Varier, R. A., Balasubramanyam, K., Pradhan, S. K., Dasgupta, D., Sriram, S., Agrawal, S., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.063933 · Cited by 95
Ye, X.-W., Zheng, Y., Duan, Y., Wang, M., Yu, B., Ren, J., Ma, J., Zhang, E., & Liu, H. (2014) · MedChemComm · doi:10.1039/c4md00031e · Cited by 95
Eggert, E., Hillig, R. C., Koehr, S., Stöckigt, D., Weiske, J., Barak, N. N., Mowat, J., Brumby, T., Christ, C. D., ter Laak, A., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01890 · Cited by 95
Allan, M., Manku, S., Therrien, É., Nguyen, N. N. M., Styhler, S., Robert, M., Goulet, A.-C., Petschner, A. J., Rahil, G., MacLeod, A. R., et al. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.12.075 · Cited by 94
Anglin, J. L., Deng, L., Yao, Y., Cai, G.-B., Liu, Z., Jiang, H., Cheng, G., Chen, P., Dong, S., & Song, Y. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300917h · Cited by 94
Protein arginine methyltransferase 6 regulates multiple aspects of gene expression
Harrison, M. J., Tang, Y., & Dowhan, D. H. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkp1203 · Cited by 94
Wu, F., Zhou, C., Yao, Y., Wei, L., Feng, Z., Deng, L., & Song, Y. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01361 · Cited by 94
Getlik, M., Smil, D. V., Zepeda‐Velázquez, C., Bolshan, Y., Poda, G. I., Wu, H. Y., Dong, A., Kuznetsova, E., Marcellus, R. C., Senisterra, G. A., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01630 · Cited by 94
Xu, X., Hoang, S. A., Mayo, M. W., & Bekiranov, S. (2010) · BMC Bioinformatics · doi:10.1186/1471-2105-11-396 · Cited by 93
Suzuki, T., Ozasa, H., Itoh, Y., Zhan, P., Sawada, H., Mino, K., Walport, L. J., Ohkubo, R., Kawamura, A., Yonezawa, M., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400624b · Cited by 93
Enantioselective synthesis of tranylcypromine analogues as lysine demethylase (LSD1) inhibitors
Benelkebir, H., Hodgkinson, C., Duriez, P. J., Hayden, A. L., Bulleid, R. A., Crabb, S. J., Packham, G., & Ganesan, A. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.02.017 · Cited by 92
Kohlmann, A., Schoch, C., Dugas, M., Schnittger, S., Hiddemann, W., Kern, W., & Haferlach, T. (2005) · Leukemia · doi:10.1038/sj.leu.2403746 · Cited by 92
Hao, C., Wang, L., Peng, S., Cao, M., Li, H., Hu, J., Huang, X., Liu, W., Zhang, H., Wu, S., et al. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.11.024 · Cited by 92
Mitchell, L. H., Boriack-Sjodin, P. A., Smith, S., Thomenius, M., Rioux, N., Munchhof, M., Mills, J. E., Klaus, C., Totman, J., Riera, T. V., et al. (2016) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.5b00272 · Cited by 91
Zhou, X., & Mā, H. (2008) · BMC Evolutionary Biology · doi:10.1186/1471-2148-8-294 · Cited by 91
Zhu, Q., Huang, Y., Marton, L. J., Woster, P. M., Davidson, N. E., & Casero, R. A. (2011) · Amino Acids · doi:10.1007/s00726-011-1004-1 · Cited by 90
PHF2 histone demethylase acts as a tumor suppressor in association with p53 in cancer
Lee, K.-H., Park, J.-W., Sung, H.-S., Choi, Y.-J., Kim, W., Lee, H. S., Chung, H.-J., Shin, H.-W., Cho, C.-H., Kim, T.-Y., et al. (2014) · Oncogene · doi:10.1038/onc.2014.219 · Cited by 89
Heinke, R., Spannhoff, A., Meier, R., Trojer, P., Bauer, I., Jung, M., & Sippl, W. (2008) · ChemMedChem · doi:10.1002/cmdc.200800301 · Cited by 89
Optimization of pyrazole inhibitors of Coactivator Associated Arginine Methyltransferase 1 (CARM1)
Huynh, T., Chen, Z., Pang, S., Geng, J., Bandiera, T., Bindi, S., Vianello, P., Roletto, F., Thieffine, S., Galvani, A. P., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.04.075 · Cited by 88
Cheng, D., Valente, S., Castellano, S., Sbardella, G., Santo, R. D., Costi, R., Bedford, M. T., & Mai, A. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200453n · Cited by 88
Nicholas, C., Yang, J., Peters, S. B., Bill, M. A., Baiocchi, R. A., Yan, F., Sif, S., Tae, S., Gaudio, E., Wu, X., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074710 · Cited by 88
Maes, T., Mascaró, C., Ortega, A., Lunardi, S., Ciceri, F., Somervaille, T. C. P., & Buesa, C. (2015) · Epigenomics · doi:10.2217/epi.15.9 · Cited by 88
Baker, T. E., Nerle, S., Pritchard, J. R., Zhao, B., Rivera, V. M., Garner, A. P., & Gonzalvez, F. (2015) · Oncotarget · doi:10.18632/oncotarget.5066 · Cited by 85
Enzymatic demethylation of calf thymus histones
Paik, W. K., & Kim, S. (1973) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(73)91383-1 · Cited by 85
Arginine Methylation Regulates Telomere Length and Stability
Mitchell, T. R. H., Glenfield, K., Jeyanthan, K., & Zhu, X. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00009-09 · Cited by 85
Serce, N. B., Gnatzy, A., Steiner, S., Lorenzen, H., Kirfel, J., & Buettner, R. (2012) · BMC Clinical Pathology · doi:10.1186/1472-6890-12-13 · Cited by 84
Duan, L., Rai, G., Roggero, C. M., Zhang, Q.-J., Wei, Q., Ma, S. H., Zhou, Y., Santoyo, J., Martínez, E. D., Xiao, G., et al. (2015) · Chemistry & Biology · doi:10.1016/j.chembiol.2015.08.007 · Cited by 83
Chen, B., Yu, M., Chang, Q., Lu, Y., Thakur, C., Ma, D., Yi, Z., & Chen, F. (2013) · Oncotarget · doi:10.18632/oncotarget.1155 · Cited by 83
Clinical evaluation of PRMT1 gene expression in breast cancer
Mathioudaki, K., Scorilas, A., Ardavanis, A. S., Lymberi, P., Tsiambas, E., Devetzi, M., Apostolaki, A., & Talieri, M. (2011) · Tumor Biology · doi:10.1007/s13277-010-0153-2 · Cited by 82
Du, J., Ma, Y., Ma, P., Wang, S., & Fan, Z. (2012) · Stem Cells · doi:10.1002/stem.1255 · Cited by 82
A Cell‐Permeable Ester Derivative of the JmjC Histone Demethylase Inhibitor IOX1
Schiller, R., Scozzafava, G., Tumber, A., Wickens, J. R., Bush, J. T., Rai, G., Lejeune, C., Choi, H., Yeh, T., Chan, M. C., et al. (2014) · ChemMedChem · doi:10.1002/cmdc.201300428 · Cited by 82
Studies on the catalytic domains of multiple JmjC oxygenases using peptide substrates
Williams, S. T., Walport, L. J., Hopkinson, R. J., Madden, S. K., Chowdhury, R., Schofield, C. J., & Kawamura, A. (2014) · Epigenetics · doi:10.4161/15592294.2014.983381 · Cited by 82
Jack, A. P. M., Bussemer, S., Hahn, M., Pünzeler, S., Snyder, M., Wells, M. B., Csankovszki, G., Solovei, I. V., Schotta, G., & Hake, S. B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0051765 · Cited by 81
Baldwin, R. M., Morettin, A., Paris, G., Goulet, I., & Côté, J. (2012) · Cell Cycle · doi:10.4161/cc.22871 · Cited by 80
Structural insights into a novel histone demethylase PHF8
Yu, L., Wang, Y., Huang, S., Wang, J., Deng, Z., Zhang, Q., Wu, W., Zhang, X., Liu, Z., Gong, W., et al. (2010) · Cell Research · doi:10.1038/cr.2010.8 · Cited by 80
Exploiting an Allosteric Binding Site of PRMT3 Yields Potent and Selective Inhibitors
Liu, F., Li, F., Ma, A., Dobrovetsky, E., Dong, A., Gao, C., Korboukh, I., Liu, J., Smil, D. V., Brown, P. J., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm3018332 · Cited by 80
Self-citationGoyama, S., Nitta, E., Yoshino, T., Kako, S., Watanabe‐Okochi, N., Shimabe, M., Imai, Y., Takahashi, K., & Kurokawa, M. (2009) · Leukemia · doi:10.1038/leu.2009.202 · Cited by 80
Liang, X., Zeng, J., Wang, L., Fang, M., Wang, Q., Zhao, M., Xu, X., Liu, Z., Li, W., Liu, S., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069784 · Cited by 79
Lysine‐Specific Demethylase 1‐Selective Inactivators: Protein‐Targeted Drug Delivery Mechanism
Ogasawara, D., Itoh, Y., Tsumoto, H., Kakizawa, T., Mino, K., Fukuhara, K., Nakagawa, H., Hasegawa, M., Sasaki, R., Mizukami, T., et al. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201303999 · Cited by 79
Discovery of Potent and Selective Inhibitors for G9a-Like Protein (GLP) Lysine Methyltransferase
Xiong, Y., Li, F., Babault, N., Dong, A., Zeng, H., Wu, H., Chen, X., Arrowsmith, C. H., Brown, P. J., Liu, J., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01645 · Cited by 79
Self-citationAberrant expression of tumor suppressors CADM1 and 4.1B in invasive lesions of primary breast cancer
Takahashi, Y., Iwai, M., Kawai, T., Arakawa, A., Ito, T., Sakurai‐Yageta, M., Ito, A., Goto, A., Saito, M., Kasumi, F., et al. (2011) · Breast Cancer · doi:10.1007/s12282-011-0272-7 · Cited by 78
CARM1 and PRMT1 are dysregulated in lung cancer without hierarchical features
Akoum, R. E., Gauchotte, G., Oussalah, A., Wissler, M.-P., Clément-Duchêne, C., Vignaud, J.-M., Guéant, J., & Namour, F. (2013) · Biochimie · doi:10.1016/j.biochi.2013.10.021 · Cited by 78
Borkin, D., Pollock, J., Kempińska, K., Purohit, T., Li, X., Wen, B., Zhao, T., Miao, H. Z., Shukla, S., He, M., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01305 · Cited by 77
A Medicinal Chemistry Perspective for Targeting Histone H3 Lysine-79 Methyltransferase DOT1L
Anglin, J. L., & Song, Y. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm4007752 · Cited by 76
Sakamoto, L. C., de Andrade, R. V., Felipe, M. S. S., Motoyama, A. B., & Pittella-Silva, F. (2014) · Leukemia Research · doi:10.1016/j.leukres.2014.01.013 · Cited by 75
Discovery and Mechanistic Study of a Class of Protein Arginine Methylation Inhibitors
Feng, Y., Li, M., Wang, B., & Zheng, Y. G. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100416n · Cited by 75
Zhou, P., Wang, Z., Yuan, X., Zhou, C., Liu, L., Wan, X., Zhang, F., Ding, X., Wang, C., Xiong, S., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.439729 · Cited by 75
Gooden, D. M., Schmidt, D. M. Z., Pollock, J. A., Kabadi, A. M., & McCafferty, D. G. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.01.003 · Cited by 75
Kim, T., Fuchs, J. R., Schwartz, E. B., Abdelhamid, D. S., Etter, J. P., Berry, W. L., Li, C., Ihnat, M. A., Li, P., & Janknecht, R. (2014) · Europe PMC (PubMed Central) · Cited by 75
Structure of the Epigenetic Oncogene MMSET and Inhibition by N-Alkyl Sinefungin Derivatives
Tisi, D., Chiarparin, E., Tamanini, E., Pathuri, P., Coyle, J. E., Hold, A., Holding, F. P., Amin, N., Martin, A. C. L., Rich, S. J., et al. (2016) · ACS Chemical Biology · doi:10.1021/acschembio.6b00308 · Cited by 75
Wang, J., Chen, L., Sinha, S. H., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300521m · Cited by 74
Kung, P., Rui, E. Y., Bergqvist, S., Bingham, P., Braganza, J., Collins, M. R., Cui, M., Diehl, W. C., Dinh, D. M., Fan, C., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00515 · Cited by 74
Low Molecular Weight Amidoximes that Act as Potent Inhibitors of Lysine-Specific Demethylase 1
Hazeldine, S. T., Pachaiyappan, B., Steinbergs, N., Nowotarski, S. L., Hanson, A. S., Casero, R. A., & Woster, P. M. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm3002845 · Cited by 73
Janzer, A., Stamm, K., Becker, A., Zimmer, A., Buettner, R., & Kirfel, J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.341040 · Cited by 73
MMSET Is Highly Expressed and Associated with Aggressiveness in Neuroblastoma
Hudlebusch, H. R., Skotte, J., Santoni‐Rugiu, E., Zimling, Z. G., Lees, M. J., Simon, R., Sauter, G., Rota, R., Ioris, M. A. D., Quarto, M., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3810 · Cited by 73
Epigenetic regulation of androgen receptor signaling in prostate cancer
Gao, L., & Alumkal, J. J. (2010) · Epigenetics · doi:10.4161/epi.5.2.10778 · Cited by 73
Crystal Structure and Functional Analysis of JMJD5 Indicate an Alternate Specificity and Function
Rizzo, P. A. D., Krishnan, S., & Trievel, R. C. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.00513-12 · Cited by 73
Williams, D. E., Dalisay, D. S., Li, F., Amphlett, J. T. M., Maneerat, W., Chavez, M. A. G., Wang, Y. A., Matainaho, T. K., Yu, W., Brown, P. J., et al. (2012) · Organic Letters · doi:10.1021/ol303416k · Cited by 72
Kleinschmidt, M. A., de Graaf, P., van Teeffelen, H. A. A. M., & Timmers, H. T. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041446 · Cited by 72
Westaway, S. M., Preston, A. G. S., Barker, M. D., Brown, F., Brown, J. A., Campbell, M. J., Chung, C., Drewes, G., Eagle, R., Garton, N. S., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01538 · Cited by 72
Tortorici, M., Borrello, M. T., Tardugno, M., Chiarelli, L. R., Pilotto, S., Ciossani, G., Vellore, N. A., Bailey, S. G., Cowan, J., O'Connell, M. A., et al. (2013) · ACS Chemical Biology · doi:10.1021/cb4001926 · Cited by 71
Essential role of DOT1L in maintaining normal adult hematopoiesis
Nguyen, A. T., He, J., Taranova, O., & Zhang, Y. (2011) · Cell Research · doi:10.1038/cr.2011.115 · Cited by 71
Discovery of A-893, A New Cell-Active Benzoxazinone Inhibitor of Lysine Methyltransferase SMYD2
Sweis, R. F., Wang, Z., Algire, M. A., Arrowsmith, C. H., Brown, P. J., Chiang, G. G., Guo, J. Q., Jakob, C. G., Kennedy, S., Li, F., et al. (2015) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.5b00124 · Cited by 71
Youn, M., Yokoyama, A., Fujiyama, S., Ohtake, F., Minehata, K., Yasuda, H., Suzuki, T., Kato, S., & Imai, Y. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.323105 · Cited by 70
An enzyme-coupled ultrasensitive luminescence assay for protein methyltransferases
Ibáñez, G., McBean, J. L., Astudillo, Y. M., & Luo, M. (2010) · Analytical Biochemistry · doi:10.1016/j.ab.2010.03.010 · Cited by 70
Dhar, S. S., Alam, H., Li, N., Wagner, K. W., Chung, J., Ahn, Y. W., & Lee, M. G. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.521625 · Cited by 69
Woon, E. C. Y., Tumber, A., Kawamura, A., Hillringhaus, L., Ge, W., Rose, N. R., Ma, J. H. Y., Chan, M. C., Walport, L. J., Che, K. H., et al. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201107833 · Cited by 69
Wan, H., Huynh, T., Pang, S., Geng, J., Vaccaro, W. D., Poss, M. A., Trainor, G. L., Lorenzi, M. V., Gottardis, M. M., Jayaraman, L., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.07.040 · Cited by 68
Dillon, M., Bachovchin, D. A., Brown, S. J., Finn, M. G., Rosen, H., Cravatt, B. F., & Mowen, K. A. (2012) · ACS Chemical Biology · doi:10.1021/cb300024c · Cited by 68
Small-Molecule Inhibitors of SETD8 with Cellular Activity
Blum, G., Ibáñez, G., Rao, X., Shum, D., Radu, C., Djaballah, H., Rice, J. C., & Luo, M. (2014) · ACS Chemical Biology · doi:10.1021/cb500515r · Cited by 68
Takemoto, Y., Ito, A., Niwa, H., Okamura, M., Fujiwara, T., Hirano, T., Handa, N., Umehara, T., Sonoda, T., Ogawa, K., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01732 · Cited by 68
Bromo-deaza-SAH: A potent and selective DOT1L inhibitor
Yu, W., Smil, D. V., Li, F., Tempel, W., Fedorov, O., Nguyen, K. T., Bolshan, Y., Al‐awar, R., Knapp, S., Arrowsmith, C. H., et al. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.01.049 · Cited by 67
de Freitas, R. F., Eram, M. S., Smil, D. V., Szewczyk, M. M., Kennedy, S., Brown, P. J., Santhakumar, V., Baršytė-Lovejoy, D., Arrowsmith, C. H., Vedadi, M., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00668 · Cited by 67
Effects of a novel arginine methyltransferase inhibitor on T‐helper cell cytokine production
Bonham, K. S., Hemmers, S., Lim, Y., Hill, D. M., Finn, M. G., & Mowen, K. A. (2010) · FEBS Journal · doi:10.1111/j.1742-4658.2010.07623.x · Cited by 65
Development and evaluation of selective, reversible LSD1 inhibitors derived from fragments
Hitchin, J. R., Blagg, J., Burke, R., Burns, S., Cockerill, M. J., Fairweather, E. E., Hutton, C. P., Jordan, A. M., McAndrew, C., Mirza, A. R., et al. (2013) · MedChemComm · doi:10.1039/c3md00226h · Cited by 65
Chemical Probes of Histone Lysine Methyltransferases
Kanıskan, H. Ü., & Jin, J. J. (2014) · ACS Chemical Biology · doi:10.1021/cb500785t · Cited by 65
Self-citationSong, X., Gao, T., Wang, N., Feng, Q., You, X., Ye, T., Lei, Q., Zhu, Y., Xiong, M., Xia, Y., et al. (2016) · Scientific Reports · doi:10.1038/srep20864 · Cited by 65
An Iridium(III) Complex Inhibits JMJD2 Activities and Acts as a Potential Epigenetic Modulator
Liu, L., Lu, L., Zhong, H., He, B., Kwong, D. W. J., Ma, D., & Leung, C. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00375 · Cited by 65
Discovery of Novel Dot1L Inhibitors through a Structure-Based Fragmentation Approach
Chen, C., Zhu, H. Y. H., Stauffer, F., Caravatti, G., Vollmer, S., Machauer, R., Holzer, P., Möbitz, H., Scheufler, C., Klumpp, M., et al. (2016) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.6b00167 · Cited by 65
Yang, X., Li, F., Konze, K. D., Meslamani, J. E., Ma, A., Brown, P. J., Zhou, M., Arrowsmith, C. H., Kanıskan, H. Ü., Vedadi, M., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00855 · Cited by 65
Self-citationDepletion of JARID1B induces cellular senescence in human colorectal cancer
Ohta, K., Haraguchi, N., KANO, Y., Kagawa, Y., Konno, M., Nishikawa, S., Hamabe, A., Hasegawa, S., Ogawa, H., Fukusumi, T., et al. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.1799 · Cited by 64
Deregulation of protein methylation in melanoma
Limm, K., Ott, C., Wallner, S., Mueller, D. W., Oefner, P. J., Hellerbrand, C., & Bosserhoff, A. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2012.11.026 · Cited by 63
Histone demethylase KDM2A promotes tumor cell growth and migration in gastric cancer
Huang, Y., Liu, Y., Yu, L., Chen, J., Hou, J., Cui, L., Ma, D., & Wang-kun, L. (2014) · Tumor Biology · doi:10.1007/s13277-014-2630-5 · Cited by 63
Discovery and Optimization of Tetramethylpiperidinyl Benzamides as Inhibitors of EZH2
Nasveschuk, C. G., Gagnon, A., Garapaty, S., Balasubramanian, S., Campbell, R., Lee, C., Zhao, F., Bergeron, L., Cummings, R. T., Trojer, P., et al. (2014) · ACS Medicinal Chemistry Letters · doi:10.1021/ml400494b · Cited by 63
Westaway, S. M., Preston, A. G. S., Barker, M. D., Brown, F., Brown, J. A., Campbell, M. J., Chung, C., Diallo, H., Douault, C., Drewes, G., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01537 · Cited by 63
Structure-Based Design of a Novel SMYD3 Inhibitor that Bridges the SAM-and MEKK2-Binding Pockets
Aller, G. S. V., Graves, A. P., Elkins, P. A., Bonnette, W. G., McDevitt, P. J., Zappacosta, F., Annan, R. S., Dean, T. W., Su, D., Carpenter, C. L., et al. (2016) · Structure · doi:10.1016/j.str.2016.03.010 · Cited by 63
Lingel, A., Sendzik, M., Huang, Y. R., Shultz, M. D., Cantwell, J., Dillon, M. P., Fu, X., Fuller, J., Gabriel, T., Gu, J., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01473 · Cited by 63
Brustel, J., Tardat, M., Kirsh, O., Grimaud, C., & Julien, E. (2011) · Trends in Cell Biology · doi:10.1016/j.tcb.2011.04.006 · Cited by 62
Glimpses of evolution: heterochromatic histone H3K9 methyltransferases left its marks behind
Krauß, V. (2007) · Genetica · doi:10.1007/s10709-007-9184-z · Cited by 62
Hernando, H., Gelato, K. A., Lesche, R., Beckmann, G., Koehr, S., Otto, S., Steigemann, P., & Stresemann, C. (2015) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-15-0486 · Cited by 62
Colon cancer and protein arginine methyltransferase 1 gene expression.
Παπαδοκωστοπούλου, Α., Mathioudaki, K., Scorilas, A., Xynopoulos, D., Ardavanis, A. S., Kouroumalis, E., & Talieri, M. (2009) · PubMed · Cited by 61
Joshi, P., Carrington, E. A., Wang, L., Ketel, C. S., Miller, E., Jones, R. S., & Simon, J. A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804442200 · Cited by 61
Histone Methyltransferase Inhibitors: Novel Epigenetic Agents for Cancer Treatment
Zagni, C., Chiacchio, U., & Rescifina, A. (2012) · Current Medicinal Chemistry · doi:10.2174/092986713804806667 · Cited by 61
Oncogenic Features of PHF8 Histone Demethylase in Esophageal Squamous Cell Carcinoma
Sun, X., Qiu, J. J., Zhu, S., Cao, B., Sun, L., Li, S., Li, P., Zhang, S., & Dong, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077353 · Cited by 60
Gao, R., Dong, R., Du, J., Ma, P., Wang, S., & Fan, Z. (2013) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-013-1633-7 · Cited by 60
Development of novel bisubstrate-type inhibitors of histone methyltransferase SET7/9
Mori, S., Iwase, K., Iwanami, N., Tanaka, Y., Kagechika, H., & Hirano, T. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.10.022 · Cited by 60
Meng, F., Cheng, S.-F., Ding, H., Liu, S., Liu, Y., Zhu, K., Chen, S., Lu, J., Xie, Y., Li, L., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01154 · Cited by 60
PRMT11: a new Arabidopsis MBD7 protein partner with arginine methyltransferase activity
Scebba, F., Bastiani, M. D., Bernacchia, G., Andreucci, A. C., Galli, A., & Pitto, L. (2007) · The Plant Journal · doi:10.1111/j.1365-313x.2007.03238.x · Cited by 59
Chen, J., Levant, B., Jiang, C., Keck, T. M., Newman, A. H., & Wang, S. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401798r · Cited by 59
Vianello, P., Botrugno, O. A., Cappa, A., Ciossani, G., Dessanti, P., Mai, A., Mattevi, A., Meroni, G., Minucci, S., Thaler, F., et al. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.08.068 · Cited by 59
Link, P. A., Gangisetty, O., James, S. R., Woloszynska‐Read, A., Tachibana, M., Shinkai, Y., & Karpf, A. R. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0497 · Cited by 59
On the Histone Lysine Methyltransferase Activity of Fungal Metabolite Chaetocin
Cherblanc, F., Chapman, K. L., Reid, J., Borg, A. J., Sundriyal, S., Alcázar‐Fuoli, L., Bignell, E., Demetriades, M., Schofield, C. J., DiMaggio, P. A., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm401063r · Cited by 57
1,2-Diamines as inhibitors of co-activator associated arginine methyltransferase 1 (CARM1)
Therrien, É., Larouche, G., Manku, S., Allan, M., Nguyen, N. N. M., Styhler, S., Robert, M., Goulet, A.-C., Besterman, J. M., Nguyen, H., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.09.110 · Cited by 56
Structural Basis for Human PHF2 Jumonji Domain Interaction with Metal Ions
Horton, J. R., Upadhyay, A. K., Hashimoto, H., Zhang, X., & Cheng, X. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.12.013 · Cited by 54
Weller, R. L., & Rajski, S. R. (2005) · ChemBioChem · doi:10.1002/cbic.200500362 · Cited by 53
Structural definitions of Jumonji family demethylase selectivity
Pilka, E. S., James, T., & Lisztwan, J. H. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.12.013 · Cited by 53
Protein Arginine Methyltransferase 6 Regulates Embryonic Stem Cell Identity
Lee, Y. H., Ma, H., Tan, T. Z., Ng, S.-S., Soong, R., Mori, S., Fu, X.-Y., Zernicka‐Goetz, M., & Wu, Q. (2012) · Stem Cells and Development · doi:10.1089/scd.2011.0330 · Cited by 53
Synthesis and evaluation of carbocyanine dyes as PRMT inhibitors and imaging agents
Sinha, S. H., Owens, E. A., Feng, Y., Yang, Y.-T., Xie, Y., Tu, Y., Henary, M., & Zheng, Y. G. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.06.017 · Cited by 53
Medicinal Chemistry Insights in the Discovery of Novel LSD1 Inhibitors
Wang, X., Huang, B., Suzuki, T., Liu, X., & Zhan, P. (2015) · Epigenomics · doi:10.2217/epi.15.86 · Cited by 52
The histone demethylase PHF8 is an oncogenic protein in human non-small cell lung cancer
Shen, Y., Pan, X., & Zhao, H. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.07.076 · Cited by 51
Synthesis and Evaluation of Novel Cyclic Peptide Inhibitors of Lysine-Specific Demethylase 1
Kumarasinghe, I. R., & Woster, P. M. (2013) · ACS Medicinal Chemistry Letters · doi:10.1021/ml4002997 · Cited by 51
Structural insights into a dual-specificity histone demethylase ceKDM7A from Caenorhabditis elegans
Yang, Y., Hu, L., Wang, P., Hou, H., Lin, Y., Liu, Y., Li, Z., Gong, R., Xiang, F., Zhou, L., et al. (2010) · Cell Research · doi:10.1038/cr.2010.86 · Cited by 51
Docking and Linking of Fragments To Discover Jumonji Histone Demethylase Inhibitors
Korczynska, M., Le, D. D., Younger, N. S., Gregori‐Puigjané, E., Tumber, A., Krojer, T. J., Velupillai, S., Gileadi, C., Nowak, R. P., Iwasa, E., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01527 · Cited by 51
Chemical Inhibition of Protein Methyltransferases
Schapira, M. (2016) · Cell chemical biology · doi:10.1016/j.chembiol.2016.07.014 · Cited by 51
Rogawski, D. S., Grembecka, J. E., & Cierpicki, T. (2016) · Future Medicinal Chemistry · doi:10.4155/fmc-2016-0071 · Cited by 51
Identification of Jumonji AT-Rich Interactive Domain 1A Inhibitors and Their Effect on Cancer Cells
Itoh, Y., Sawada, H., SUZUKI, M. T., Tojo, T., Sasaki, R., Hasegawa, M., Mizukami, T., & Suzuki, T. (2015) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.5b00083 · Cited by 50
3,5-Diamino-1,2,4-triazoles as a novel scaffold for potent, reversible LSD1 (KDM1A) inhibitors
Kutz, C. J., Holshouser, S. L., Marrow, E. A., & Woster, P. M. (2014) · MedChemComm · doi:10.1039/c4md00283k · Cited by 50
Evidence for a tumour suppressor function of SETD2 in human breast cancer: a new hypothesis.
Newbold, R. F., & Mokbel, K. (2010) · PubMed · Cited by 50
Analogues of the Natural Product Sinefungin as Inhibitors of EHMT1 and EHMT2
Devkota, K., Lohse, B., Liu, Q., Wang, M., Stærk, D., Berthelsen, J., & Clausen, R. P. (2014) · ACS Medicinal Chemistry Letters · doi:10.1021/ml4002503 · Cited by 50
Kondengaden, S. M., Luo, L., Huang, K., Zhu, M., Zang, L., Bataba, E., Wang, R., Luo, C., Wang, B., Li, K. K., et al. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.06.028 · Cited by 50
Liang, J., Zhang, B., Labadie, S. S., Ortwine, D. F., Vinogradova, M. V., Kiefer, J. R., Gehling, V. S., Harmange, J.-C., Cummings, R. T., Lai, T., et al. (2016) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2016.06.078 · Cited by 50
Catalytic Mechanism Investigation of Lysine-Specific Demethylase 1 (LSD1): A Computational Study
Kong, X., Ouyang, S., Liang, Z. T., Lu, J., Chen, L., Shen, B., Li, D., Zheng, M., Li, K. K., Luo, C., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025444 · Cited by 49
Fluorescence-Based Methods for Screening Writers and Readers of Histone Methyl Marks
Allali‐Hassani, A., Wasney, G. A., Siarheyeva, A., Hajian, T., Arrowsmith, C. H., & Vedadi, M. (2011) · SLAS DISCOVERY · doi:10.1177/1087057111422256 · Cited by 49
Cited by
Advancing targeted protein degradation for cancer therapy
Dale, B., Cheng, M., Park, K.-S., Kaniskan, H. Ü., Xiong, Y., & Jin, J. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-021-00365-x · Cited by 632
Self-citationLSD1/KDM1A inhibitors in clinical trials: advances and prospects
Fang, Y., Liao, G., & Yu, B. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0811-9 · Cited by 438
Epigenetic tools (The Writers, The Readers and The Erasers) and their implications in cancer therapy
Biswas, S., & Rao, C. M. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.08.021 · Cited by 389
Pathogenesis of allergic diseases and implications for therapeutic interventions
Wang, J., Zhou, Y., Zhang, H., Hu, L., Liu, J., Wang, L., Wang, T., Zhang, H., Cong, L., & Wang, Q. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01344-4 · Cited by 376
Epigenetic modulation of antitumor immunity for improved cancer immunotherapy
Dai, E., Zhu, Z., Wahed, S., Qu, Z., Storkus, W. J., & Guo, Z. S. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01464-x · Cited by 328
Metadata
- Authors
- Kaniskan, H. Ü., Martini, M. L., & Jin, J.
- Venue
- Chemical Reviews
- Publisher
- American Chemical Society (ACS)
- Published
- 2017-03-24
- Volume
- 118
- Issue
- 3
- Pages
- 989-1068
- ISSN
- 0009-2665 (ISSN-L)
- 1520-6890
- OpenAlex
- W2602027562
- Cited by
- 297
- References
- 654
- FWCI
- 1.87
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.